Conmed (CNMD) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $33.80 +3.87%
EPS Growth %: -3.5%
Financial Fact:
Net sales: 184.79M
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: -3.5%
Financial Fact:
Net sales: 184.79M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Conmed (NASDAQ: CNMD) reported Q2 EPS of $0.47, $0.01 better than the analyst estimate of $0.46. Revenue for the quarter came in at $193.4 million versus the consensus estimate of $191.48 million.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- Nike names former Pfizer CFO David Denton as new finance chief
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
